Bsenexus Terminal Open Filings terminal →
Other BSE: 524816

Natco Pharma Ltd

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

NATCO Pharma Limited announced conclusion of U.S. FDA Inspection at our Formulation Plant located at Kothur, Hyderabad